AU2022297513A1 - Method of regulating gene expression - Google Patents
Method of regulating gene expression Download PDFInfo
- Publication number
- AU2022297513A1 AU2022297513A1 AU2022297513A AU2022297513A AU2022297513A1 AU 2022297513 A1 AU2022297513 A1 AU 2022297513A1 AU 2022297513 A AU2022297513 A AU 2022297513A AU 2022297513 A AU2022297513 A AU 2022297513A AU 2022297513 A1 AU2022297513 A1 AU 2022297513A1
- Authority
- AU
- Australia
- Prior art keywords
- gene expression
- regulating gene
- regulating
- expression
- gene
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000014509 gene expression Effects 0.000 title 1
- 230000001105 regulatory effect Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M27/00—Drainage appliance for wounds or the like, i.e. wound drains, implanted drains
- A61M27/002—Implant devices for drainage of body fluids from one part of the body to another
- A61M27/006—Cerebrospinal drainage; Accessories therefor, e.g. valves
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Ophthalmology & Optometry (AREA)
- Otolaryngology (AREA)
- Anesthesiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US202163214239P | 2021-06-23 | 2021-06-23 | |
US63/214,239 | 2021-06-23 | ||
PCT/US2022/034706 WO2022271938A1 (en) | 2021-06-23 | 2022-06-23 | Method of regulating gene expression |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2022297513A1 true AU2022297513A1 (en) | 2024-01-18 |
Family
ID=84544860
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2022297513A Pending AU2022297513A1 (en) | 2021-06-23 | 2022-06-23 | Method of regulating gene expression |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP4359054A1 (en) |
AU (1) | AU2022297513A1 (en) |
CA (1) | CA3225436A1 (en) |
WO (1) | WO2022271938A1 (en) |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6197300B1 (en) * | 1997-08-12 | 2001-03-06 | Smithkline Beecham Corporation | ftsZ |
BR9812650A (en) * | 1997-09-17 | 2000-08-22 | Univ East Carolina | nucleic acids hybridizing multiple labeling, preparation of the same, compositions, formulation, kits and applications |
EP1135113B1 (en) * | 1998-11-05 | 2008-10-01 | Thomas Jefferson University | Treatment of parkinson's disease with oligonucleotides |
WO2017117138A1 (en) * | 2015-12-28 | 2017-07-06 | Cognost Therapeutics Inc. | An apparatus and method for cerebral microdialysis to treat neurological disease, including alzheimer's, parkinson's or multiple sclerosis |
CA3013898A1 (en) * | 2016-02-04 | 2017-08-10 | Zhenglun Zhu | Treatment and diagnosis of inflammatory disorders |
AU2020271894A1 (en) * | 2019-04-11 | 2021-12-02 | Enclear Therapies, Inc. | Methods of amelioration of cerebrospinal fluid and devices and systems therefor |
-
2022
- 2022-06-23 WO PCT/US2022/034706 patent/WO2022271938A1/en active Application Filing
- 2022-06-23 EP EP22829302.3A patent/EP4359054A1/en active Pending
- 2022-06-23 AU AU2022297513A patent/AU2022297513A1/en active Pending
- 2022-06-23 CA CA3225436A patent/CA3225436A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
CA3225436A1 (en) | 2022-12-29 |
EP4359054A1 (en) | 2024-05-01 |
WO2022271938A9 (en) | 2023-12-07 |
WO2022271938A1 (en) | 2022-12-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP4070229A4 (en) | Method and system for self-aggregation of personal data and control thereof | |
EP3833357A4 (en) | Alternative splicing regulation of gene expression and therapeutic methods | |
EP3697911A4 (en) | Method for regulating gene expression | |
EP3800258A4 (en) | Novel promoter derived from organic acid-resistant yeast and method for expression of target gene by using same | |
EP4100255A4 (en) | Method of printing | |
GB202200070D0 (en) | Method of culture | |
EP4010004A4 (en) | Compositions and methods for modulation of gene expression | |
EP4012752A4 (en) | Stage and method for controlling temperature of substrate | |
EP4061947A4 (en) | Method for robust control of gene expression | |
AU2022297513A1 (en) | Method of regulating gene expression | |
EP3956459A4 (en) | Nonviral modification of t cell gene expression | |
EP3919236A4 (en) | Control system and control method of control system | |
EP3644744A4 (en) | Transbiotic regulation of bacterial gene expression | |
AU2022900309A0 (en) | Regulation of gene expression | |
EP3957410A4 (en) | Method of controlling meandering of material-to-be-rolled | |
EP4103730C0 (en) | Enzymatic method for preparation of cmp-neu5ac | |
GB202210524D0 (en) | Methods of regulating rna | |
EP3976018A4 (en) | Method of disease control | |
EP3960848A4 (en) | Method for regulation of selective differentiation of musculoskeletal stem cells | |
AU2023902151A0 (en) | Modulation of gene expression | |
AU2024901433A0 (en) | Regulation of gene expression | |
AU2020903837A0 (en) | Method of construction | |
AU2020903581A0 (en) | Method of construction | |
AU2022901265A0 (en) | Methods of culturing asparagopsis | |
AU2020902634A0 (en) | Method of treatment of cytomegalovirus |